To evaluate the different responses to immunotherapy among the subtypes, we analyzed the mRNA expression of breast cancer immune checkpoint genes, namely PD-1, PD-L1, PD-L2, LAG3, VTCN1, IDO1, and TIM3 (Figure 7A). Here, PDCD1LG2 is linked to breast carcinoma.